Stéphane Ory

Dr. Stéphane Ory

CNRS INCI UPR3212
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2003 in Current Biology
Verified
Journal Article
Closed access
SOStéphane Ory
Stéphane Ory
MZMing Zhou
Ming Zhou
TCThomas P Conrads
Thomas P Conrads
TVTimothy D Veenstra
Timothy D Veenstra
DMDeborah K Morrison
Deborah K Morrison

1 November 2001 in Molecular Cell
Verified
Journal Article
Closed access
JMJürgen Müller
Jürgen Müller
SOStéphane Ory
Stéphane Ory
TCTerry Copeland
Terry Copeland
HPHelen Piwnica-Worms
Helen Piwnica-Worms
DMDeborah K. Morrison
Deborah K. Morrison

1 July 2005 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
ODOlivier Destaing
Olivier Destaing
FSFrédéric Saltel
Frédéric Saltel
BGBenoit Gilquin
Benoit Gilquin
ACAnne Chabadel
Anne Chabadel
SKSaadi Khochbin
Saadi Khochbin
PJPierre Jurdic
Pierre Jurdic
Osteoclast maturation is accompanied by changes in podosome patterning, resulting in the formation of a peripheral belt, which requires an intact microtubule network. Here, we report that by inhibiting Rho, the podosome belt is maintained at the cell periphery despite depolymerisation of microtubules by nocodazole. Rho inhibition was correlated to the increase in microtubule stabilisation and microtubule acetylation. By microinjecting activated Rho or its activated effector mDia2 in osteoclasts, we found that the podosome belt was disrupted and the level of microtubule acetylation dramatically decreased. We further characterised the molecular mechanism responsible for microtubule deacetylation by co-immunoprecipitation experiments. We found that not only was mDia2 coprecipitating with the recently identified microtubule deacetylase HDAC6 but that it also activated the microtubule deacetylase activity of HDAC6 in an in vitro deacetylase assay. Finally, we found that during osteoclastogenesis, there is a correlation between the increase in microtubule acetylation and the podosome belt stabilisation and that if Rho is inhibited in the early stages of osteoclast differentiation, it accelerates both microtubule acetylation and podosome belt stabilisation. Altogether, our data reveal a pathway in which Rho interferes with the osteoclast maturation process by controlling the level of microtubule acetylation and actin organisation through mDIA2 and HDAC6.

2 August 2021 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
MDManon Duquenne
Manon Duquenne
CFCintia Folgueira
Cintia Folgueira
CBCyril Bourouh
Cyril Bourouh
MMMarion Millet
Marion Millet
ASAnisia Silva
Anisia Silva
VPVincent Prévot
Vincent Prévot

1 September 2008 in European Journal of Cell Biology
Verified
Journal Article
Closed access
SOStéphane Ory
Stéphane Ory
HBHélène Brazier
Hélène Brazier
GPGéraldine Pawlak
Géraldine Pawlak
ABAnne Blangy
Anne Blangy

15 December 2001 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
YZYona Zaffran
Yona Zaffran
ODOlivier Destaing
Olivier Destaing
ARAgnès Roux
Agnès Roux
SOStéphane Ory
Stéphane Ory
TNThao Nheu
Thao Nheu
AAAnne L. Astier
Anne L. Astier
Efficient T cell activation requires at least two signals, one mediated by the engagement of the TCR-CD3 complex and another one mediated by a costimulatory molecule. We recently showed that CD46, a complement regulatory receptor for C3b as well as a receptor for several pathogens, could act as a potent costimulatory molecule for human T cells, highly promoting T cell proliferation. Indeed, we show in this study that CD46/CD3 costimulation induces a synergistic activation of extracellular signal-related kinase mitogen-activated protein kinase. Furthermore, whereas T lymphocytes primarily circulate within the bloodstream, activation may induce their migration toward secondary lymphoid organs or other tissues to encounter APCs or target cells. In this study, we show that CD46/CD3 costimulation also induces drastic morphological changes of primary human T cells, as well as actin relocalization. Moreover, we show that the GTP/GDP exchange factor Vav is phosphorylated upon CD46 stimulation alone, and that CD46/CD3 costimulation induces a synergistic increase of Vav phosphorylation. These results prompted us to investigate whether CD46/CD3 costimulation induced the activation of GTPases from the Rho family. Indeed, we report that the small GTPase Rac is also activated upon CD46/CD3 costimulation, whereas no change of Rho and Cdc42 activity could be detected. Therefore, CD46 costimulation profoundly affects T cell behavior, and these results provide important data concerning the biology of primary human T cells.